ChIP revealed that NCL binds to the region of the AR promoter containing the G4-element in androgen-dependent (LNCaP/VCaP) and CRPC (22Rv1) AR-expressing tumor cells, but not in AR-negative tumor cells (PC3) (Figure 1B). This evidence concerns the gene NUCLEOLIN and neoplasm.